论文部分内容阅读
有报道，tamibarotene可使复发的急性前髓细胞白血病（APL）患者获得完全缓解。2例用以维甲酸为基础的疗法使APL病完全缓解后又复发的白血病患者口服本品（一种新合成视黄酸），一日6mg／m2以及伊达比星和阿糖胞苷，分别在第38天和第52天再次确定为已完全缓解。2例病人观察到的
It has been reported that tamibarotene can achieve complete remission in patients with relapsed acute promyelocytic leukemia (APL). Two patients with relapsed leukemia treated with retinoic acid-based therapy received oral administration of this product (a newly synthesized retinoic acid), 6 mg/m2 of ketamine, and idarubicin and cytarabine. On the 38th day and the 52nd day, they were once again determined to be completely relieved. Observed in 2 patients